Beris_Table-1

Criteria for treatment switch from imatinib to second generation TKIs

Haema 2012; 3(1): 37-44

by Nora-Athina Viniou, Panagiotis Diamantopoulos, Vassiliki Papadopoulou

1st Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, “Laiko” General Hospital, Athens

Full PDF (in Greek) |

Continue reading “Criteria for treatment switch from imatinib to second generation TKIs”

Beris_Table-1

Guidelines for the molecular monitoring of patients with CML treated with tyrosine kinase inhibitors

Haema 2012; 3(1): 57-64

by Tassoula Touloumenidou, Apostolia Papalexandri, Kostas Stamatopoulos

Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece

Full PDF (in Greek) |

Continue reading “Guidelines for the molecular monitoring of patients with CML treated with tyrosine kinase inhibitors”